InsiderTrades

Form 4 for CRH CRH plc

Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0000950170-25-033691 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2025-03-05 2025-03-03 CRH Connolly Alan See Remarks F - Tax $102.93 -11.6K 62.9K -16% -$1.20M
2025-03-05 2025-03-03 CRH Connolly Alan See Remarks A - Grant $0.00 +22.3K 74.5K +43% $0
2025-03-05 2025-03-03 CRH Connolly Alan See Remarks S - Sale $102.93 -10.7K 52.3K -17% -$1.10M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2025-03-03 F D 11,618 $102.93 62,893 D — — (F2) Mandatory sale of sufficient Ordinary Shares to cover applicable withholding tax liabilities arising in the connection with the aforementioned award. (F3) The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $102.30 and $103.535 inclusive of shares sold on the New York Stock Exchange. Full information regarding the number of Ordinary Shares sold at each separate price in the range will be provided to the SEC upon request.
2 Common Ordinary Shares 2025-03-03 A A 22,298 $0.00 74,511 D — — (F1) Reflects the vesting and release of awards granted in 2022 under the 2014 Performance Share Plan Rules on March 3, 2025 (including the award of 2,261 additional Ordinary Shares as dividend equivalents), pursuant to certification of the achievement of pre-established performance goals by the Compensation Committee of the Board of Directors of the Issuer.
3 Common Ordinary Shares 2025-03-03 S D 10,680 $102.93 52,341 D — — (F4) The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $102.30 and $103.535 inclusive of shares sold on the New York Stock Exchange. Full information regarding the number of Ordinary Shares sold at each separate price in the range will be provided to the SEC upon request. (F5) Includes 128 Ordinary Shares purchased by AC Employee Benefit Trustees Limited, as trustee for and on behalf of the Reporting Person, as sole beneficiary, pursuant to an Irish Revenue-approved broad-based employee share participation scheme. Such Ordinary Shares are subject to a minimum holding requirement of one year.